Abstract
Summary
LPI (LP Information)' newest research report, the “Biobanking Technologies Industry Forecast” looks at past sales and reviews total world Biobanking Technologies sales in 2022, providing a comprehensive analysis by region and market sector of projected Biobanking Technologies sales for 2023 through 2029. With Biobanking Technologies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biobanking Technologies industry.
This Insight Report provides a comprehensive analysis of the global Biobanking Technologies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biobanking Technologies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biobanking Technologies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biobanking Technologies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biobanking Technologies.
The global Biobanking Technologies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biobanking Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biobanking Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biobanking Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biobanking Technologies players cover Thermo Fisher, Tecan Group, Qiagen, Hamilton, Brooks Automation, TTP Labtech, VWR, Promega and Worthington, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biobanking Technologies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Segmentation by application
Regenerative Medicine
Life Science
Clinical Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Tecan Group
Qiagen
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
Worthington
Chart Industries
BD
Merck
Micronic
Panasonic
Greiner Bio One
Biokryo
Biobank
Biorep
This Insight Report provides a comprehensive analysis of the global Biobanking Technologies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biobanking Technologies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biobanking Technologies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biobanking Technologies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biobanking Technologies.
The global Biobanking Technologies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biobanking Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biobanking Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biobanking Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biobanking Technologies players cover Thermo Fisher, Tecan Group, Qiagen, Hamilton, Brooks Automation, TTP Labtech, VWR, Promega and Worthington, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biobanking Technologies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Segmentation by application
Regenerative Medicine
Life Science
Clinical Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Tecan Group
Qiagen
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
Worthington
Chart Industries
BD
Merck
Micronic
Panasonic
Greiner Bio One
Biokryo
Biobank
Biorep
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biobanking Technologies Market Size 2018-2029
2.1.2 Biobanking Technologies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Biobanking Technologies Segment by Type
2.2.1 Blood Products
2.2.2 Human Tissues
2.2.3 Cell Lines
2.2.4 Nucleic Acids
2.3 Biobanking Technologies Market Size by Type
2.3.1 Biobanking Technologies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Biobanking Technologies Market Size Market Share by Type (2018-2023)
2.4 Biobanking Technologies Segment by Application
2.4.1 Regenerative Medicine
2.4.2 Life Science
2.4.3 Clinical Research
2.5 Biobanking Technologies Market Size by Application
2.5.1 Biobanking Technologies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Biobanking Technologies Market Size Market Share by Application (2018-2023)
3 Biobanking Technologies Market Size by Player
3.1 Biobanking Technologies Market Size Market Share by Players
3.1.1 Global Biobanking Technologies Revenue by Players (2018-2023)
3.1.2 Global Biobanking Technologies Revenue Market Share by Players (2018-2023)
3.2 Global Biobanking Technologies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biobanking Technologies by Regions
4.1 Biobanking Technologies Market Size by Regions (2018-2023)
4.2 Americas Biobanking Technologies Market Size Growth (2018-2023)
4.3 APAC Biobanking Technologies Market Size Growth (2018-2023)
4.4 Europe Biobanking Technologies Market Size Growth (2018-2023)
4.5 Middle East & Africa Biobanking Technologies Market Size Growth (2018-2023)
5 Americas
5.1 Americas Biobanking Technologies Market Size by Country (2018-2023)
5.2 Americas Biobanking Technologies Market Size by Type (2018-2023)
5.3 Americas Biobanking Technologies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biobanking Technologies Market Size by Region (2018-2023)
6.2 APAC Biobanking Technologies Market Size by Type (2018-2023)
6.3 APAC Biobanking Technologies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biobanking Technologies by Country (2018-2023)
7.2 Europe Biobanking Technologies Market Size by Type (2018-2023)
7.3 Europe Biobanking Technologies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biobanking Technologies by Region (2018-2023)
8.2 Middle East & Africa Biobanking Technologies Market Size by Type (2018-2023)
8.3 Middle East & Africa Biobanking Technologies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biobanking Technologies Market Forecast
10.1 Global Biobanking Technologies Forecast by Regions (2024-2029)
10.1.1 Global Biobanking Technologies Forecast by Regions (2024-2029)
10.1.2 Americas Biobanking Technologies Forecast
10.1.3 APAC Biobanking Technologies Forecast
10.1.4 Europe Biobanking Technologies Forecast
10.1.5 Middle East & Africa Biobanking Technologies Forecast
10.2 Americas Biobanking Technologies Forecast by Country (2024-2029)
10.2.1 United States Biobanking Technologies Market Forecast
10.2.2 Canada Biobanking Technologies Market Forecast
10.2.3 Mexico Biobanking Technologies Market Forecast
10.2.4 Brazil Biobanking Technologies Market Forecast
10.3 APAC Biobanking Technologies Forecast by Region (2024-2029)
10.3.1 China Biobanking Technologies Market Forecast
10.3.2 Japan Biobanking Technologies Market Forecast
10.3.3 Korea Biobanking Technologies Market Forecast
10.3.4 Southeast Asia Biobanking Technologies Market Forecast
10.3.5 India Biobanking Technologies Market Forecast
10.3.6 Australia Biobanking Technologies Market Forecast
10.4 Europe Biobanking Technologies Forecast by Country (2024-2029)
10.4.1 Germany Biobanking Technologies Market Forecast
10.4.2 France Biobanking Technologies Market Forecast
10.4.3 UK Biobanking Technologies Market Forecast
10.4.4 Italy Biobanking Technologies Market Forecast
10.4.5 Russia Biobanking Technologies Market Forecast
10.5 Middle East & Africa Biobanking Technologies Forecast by Region (2024-2029)
10.5.1 Egypt Biobanking Technologies Market Forecast
10.5.2 South Africa Biobanking Technologies Market Forecast
10.5.3 Israel Biobanking Technologies Market Forecast
10.5.4 Turkey Biobanking Technologies Market Forecast
10.5.5 GCC Countries Biobanking Technologies Market Forecast
10.6 Global Biobanking Technologies Forecast by Type (2024-2029)
10.7 Global Biobanking Technologies Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Information
11.1.2 Thermo Fisher Biobanking Technologies Product Offered
11.1.3 Thermo Fisher Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Thermo Fisher Main Business Overview
11.1.5 Thermo Fisher Latest Developments
11.2 Tecan Group
11.2.1 Tecan Group Company Information
11.2.2 Tecan Group Biobanking Technologies Product Offered
11.2.3 Tecan Group Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Tecan Group Main Business Overview
11.2.5 Tecan Group Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Biobanking Technologies Product Offered
11.3.3 Qiagen Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 Hamilton
11.4.1 Hamilton Company Information
11.4.2 Hamilton Biobanking Technologies Product Offered
11.4.3 Hamilton Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hamilton Main Business Overview
11.4.5 Hamilton Latest Developments
11.5 Brooks Automation
11.5.1 Brooks Automation Company Information
11.5.2 Brooks Automation Biobanking Technologies Product Offered
11.5.3 Brooks Automation Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Brooks Automation Main Business Overview
11.5.5 Brooks Automation Latest Developments
11.6 TTP Labtech
11.6.1 TTP Labtech Company Information
11.6.2 TTP Labtech Biobanking Technologies Product Offered
11.6.3 TTP Labtech Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 TTP Labtech Main Business Overview
11.6.5 TTP Labtech Latest Developments
11.7 VWR
11.7.1 VWR Company Information
11.7.2 VWR Biobanking Technologies Product Offered
11.7.3 VWR Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 VWR Main Business Overview
11.7.5 VWR Latest Developments
11.8 Promega
11.8.1 Promega Company Information
11.8.2 Promega Biobanking Technologies Product Offered
11.8.3 Promega Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Promega Main Business Overview
11.8.5 Promega Latest Developments
11.9 Worthington
11.9.1 Worthington Company Information
11.9.2 Worthington Biobanking Technologies Product Offered
11.9.3 Worthington Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Worthington Main Business Overview
11.9.5 Worthington Latest Developments
11.10 Chart Industries
11.10.1 Chart Industries Company Information
11.10.2 Chart Industries Biobanking Technologies Product Offered
11.10.3 Chart Industries Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Chart Industries Main Business Overview
11.10.5 Chart Industries Latest Developments
11.11 BD
11.11.1 BD Company Information
11.11.2 BD Biobanking Technologies Product Offered
11.11.3 BD Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BD Main Business Overview
11.11.5 BD Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Biobanking Technologies Product Offered
11.12.3 Merck Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 Micronic
11.13.1 Micronic Company Information
11.13.2 Micronic Biobanking Technologies Product Offered
11.13.3 Micronic Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Micronic Main Business Overview
11.13.5 Micronic Latest Developments
11.14 Panasonic
11.14.1 Panasonic Company Information
11.14.2 Panasonic Biobanking Technologies Product Offered
11.14.3 Panasonic Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Panasonic Main Business Overview
11.14.5 Panasonic Latest Developments
11.15 Greiner Bio One
11.15.1 Greiner Bio One Company Information
11.15.2 Greiner Bio One Biobanking Technologies Product Offered
11.15.3 Greiner Bio One Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Greiner Bio One Main Business Overview
11.15.5 Greiner Bio One Latest Developments
11.16 Biokryo
11.16.1 Biokryo Company Information
11.16.2 Biokryo Biobanking Technologies Product Offered
11.16.3 Biokryo Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Biokryo Main Business Overview
11.16.5 Biokryo Latest Developments
11.17 Biobank
11.17.1 Biobank Company Information
11.17.2 Biobank Biobanking Technologies Product Offered
11.17.3 Biobank Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Biobank Main Business Overview
11.17.5 Biobank Latest Developments
11.18 Biorep
11.18.1 Biorep Company Information
11.18.2 Biorep Biobanking Technologies Product Offered
11.18.3 Biorep Biobanking Technologies Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Biorep Main Business Overview
11.18.5 Biorep Latest Developments
12 Research Findings and Conclusion